KalVista Pharmaceuticals welcomes Bethany Sensenig to its Board of Directors
– UK, Cambridge – KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) announced the appointment of Bethany Sensenig to its Board of Directors, effective as of October 1, 2025.…
– UK, Cambridge – KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) announced the appointment of Bethany Sensenig to its Board of Directors, effective as of October 1, 2025.…
– USA, NM – NTx, a life sciences company developing next-generation platforms for RNA and protein manufacturing, announced the appointment of Dave Johnson to its Board of Directors.…
– USA, NY – MiNK Therapeutics, Inc. (Nasdaq: INKT), a clinical-stage biopharmaceutical company pioneering invariant natural killer T (iNKT) cell therapies, announced the appointment of Colonel (Ret.)…
– UK, Cambridge – Arecor Therapeutics plc (LON: AREC), the biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, announced the appointment of Simon Ormiston to its Board as a Non-Executive Director and the new Chair of the Audit & Risk Committee, with immediate effect.…
– USA, CA – Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company developing and licensing advanced plant traits that enable higher yields, lower input costs, and more sustainable farming, announced the election of Kim Box to its Board of Directors.…